Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-09
DOI
10.1038/s41467-019-11875-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception
- (2018) Rob Hill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Translating in vitro ligand bias into in vivo efficacy
- (2018) Louis M. Luttrell et al. CELLULAR SIGNALLING
- Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)
- (2017) Peter S. Pang et al. EUROPEAN HEART JOURNAL
- Signaling bias in drug discovery
- (2017) Terry Kenakin Expert Opinion on Drug Discovery
- A kinetic view of GPCR allostery and biased agonism
- (2017) J Robert Lane et al. Nature Chemical Biology
- A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty
- (2017) Neil Singla et al. Journal of Pain Research
- Systematic errors in detecting biased agonism: Analysis of current methods and development of a new model-free approach
- (2017) H. Ongun Onaran et al. Scientific Reports
- Biased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased μ opioid receptor agonists
- (2016) David Winpenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Design and construction of conformational biosensors to monitor ion channel activation: A prototype FlAsH/BRET-approach to Kir3 channels
- (2016) Derek N. Robertson et al. METHODS
- Structure-based discovery of opioid analgesics with reduced side effects
- (2016) Aashish Manglik et al. NATURE
- Opportunities and challenges of the 2016 target landscape
- (2016) Kyle Lafferty-Whyte et al. NATURE REVIEWS DRUG DISCOVERY
- Structural insights into µ-opioid receptor activation
- (2015) Weijiao Huang et al. NATURE
- The clinical analgesic efficacy of buprenorphine
- (2014) R. B. Raffa et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- What is biased efficacy? Defining the relationship between intrinsic efficacy and free energy coupling
- (2014) H. Ongun Onaran et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists
- (2013) Iness Charfi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Signalling bias in new drug discovery: detection, quantification and therapeutic impact
- (2013) Terry Kenakin et al. NATURE REVIEWS DRUG DISCOVERY
- Measurements of ligand bias and functional affinity
- (2013) Terry Kenakin et al. NATURE REVIEWS DRUG DISCOVERY
- Quantifying biased agonism: understanding the links between affinity and efficacy
- (2013) Sudarshan Rajagopal NATURE REVIEWS DRUG DISCOVERY
- Chemical predictive modelling to improve compound quality
- (2013) John G. Cumming et al. NATURE REVIEWS DRUG DISCOVERY
- β-Adrenergic receptor subtype signaling in heart: From bench to bedside
- (2012) Anthony Yiu Ho Woo et al. ACTA PHARMACOLOGICA SINICA
- Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases
- (2012) Kjell Johnson et al. BIOINFORMATICS
- Drug Side-Effect Prediction Based on the Integration of Chemical and Biological Spaces
- (2012) Yoshihiro Yamanishi et al. Journal of Chemical Information and Modeling
- Differential Association of Receptor-G Complexes with -Arrestin2 Determines Recycling Bias and Potential for Tolerance of Delta Opioid Receptor Agonists
- (2012) N. Audet et al. JOURNAL OF NEUROSCIENCE
- BRET biosensors to study GPCR biology, pharmacology, and signal transduction
- (2012) Ali Salahpour Frontiers in Endocrinology
- A Simple Method for Quantifying Functional Selectivity and Agonist Bias
- (2011) Terry Kenakin et al. ACS Chemical Neuroscience
- Quantifying Ligand Bias at Seven-Transmembrane Receptors
- (2011) S. Rajagopal et al. MOLECULAR PHARMACOLOGY
- Morphine-like Opiates Selectively Antagonize Receptor-Arrestin Interactions
- (2010) Paola Molinari et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
- (2010) T. Kenakin et al. PHARMACOLOGICAL REVIEWS
- Quantifying Biological Activity in Chemical Terms: A Pharmacology Primer To Describe Drug Effect
- (2009) Terry Kenakin ACS Chemical Biology
- Sympathetic Neural Mechanisms in Human Cardiovascular Health and Disease
- (2009) Nisha Charkoudian et al. MAYO CLINIC PROCEEDINGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started